Use of FOXJ1CreER2T Mice for Inducible Deletion of Embryonic Node Gene Expression

被引:7
|
作者
Wang, Shuyun [1 ]
Ware, Stephanie M. [1 ]
机构
[1] Univ Cincinnati, Coll Med, Cincinnati Childrens Hosp, Med Ctr,Dept Pediat, Cincinnati, OH 45229 USA
关键词
Cre recombinase; fate mapping; left-right patterning; embryonic node; cilia; LEFT-RIGHT ASYMMETRY; LEFT-RIGHT AXIS; MOUSE EMBRYO; DEFECTS; ZIC3; FLOW;
D O I
10.1002/dvg.20467
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
The ciliated cells of the node of the mouse embryo contribute to the establishment of left-right patterning via generation of leftward laminar fluid flow and initiation of a left-sided morphogen gradient. Here, we identify FOXJ1CreER(2T) mice in which expression of Cre recombinase is directed to ciliated node cells. The data demonstrate that foxj1 is expressed specifically in the node throughout the developmental window critical for left-right patterning. In transgenic embryos, Cre expression is detected by immunohistochemistry in ciliated cells of the node. Rosa26R reporter mice, in which expression of lacZ is activated only after Cre-mediated recombination, demonstrate strong and uniform labeling at the node when crossed with FOXJ1CreER(2T) mice. Cell labeling occurred as early as 0- to 2-somite stages, specifically within cells of the node, and recombination was highly efficient in response to tamoxifen. FOXJ1CreER(2T) transgenic mice represent a new genetic tool for the analysis of node-specific gene expression and will also be valuable in the study of node cell lineage and temporal cell fate mapping. genesis 47:132-136, 2009. (C) 2009 Wiley-Liss, Inc.
引用
收藏
页码:132 / 136
页数:5
相关论文
共 50 条
  • [1] Generation of Nkx2-5/CreER transgenic mice for inducible Cre expression in developing hearts
    Ranjbarvaziri, Sara
    Park, Shuin
    Nguyen, Ngoc B.
    Gilmore, William B.
    Zhao, Peng
    Ardehali, Reza
    GENESIS, 2017, 55 (08)
  • [2] Foxj1 regulates left-right asymmetric gene expression during embryonic development
    Zhang, M
    Bolfing, MF
    Hackett, BP
    PEDIATRIC RESEARCH, 2002, 51 (04) : 53A - 53A
  • [3] Foxj1 regulates asymmetric gene expression during left-right axis patterning in mice
    Zhang, M
    Bolfing, MF
    Knowles, HJ
    Karnes, H
    Hackett, BP
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 324 (04) : 1413 - 1420
  • [4] Experimental autoimmune encephalomyelitis in mice with a targeted deletion of the inducible nitric oxide synthase gene: increased T-helper 1 response
    Kahl, KG
    Schmidt, HHHW
    Jung, S
    Sherman, P
    Toyka, KV
    Zielasek, E
    NEUROSCIENCE LETTERS, 2004, 358 (01) : 58 - 62
  • [5] On the use of the T-REx™ tetracycline-inducible gene expression system in vivo
    Dobrovolsky, Vasily N.
    Heflich, Robert H.
    BIOTECHNOLOGY AND BIOENGINEERING, 2007, 98 (03) : 719 - 723
  • [6] Early embryonic lethality in mice with targeted deletion of the CTP:: Phosphocholine cytidylyltransferase α gene (Pcyt1a)
    Wang, LM
    Magdaleno, S
    Tabas, I
    Jackowski, S
    MOLECULAR AND CELLULAR BIOLOGY, 2005, 25 (08) : 3357 - 3363
  • [7] Regulation of preproendothelin-1 gene expression during embryonic development in transgenic mice
    Chan, TSK
    Chung, SM
    Chung, SK
    FASEB JOURNAL, 1999, 13 (04): : A355 - A355
  • [8] Inducible gene expression with the Tet-on system in CD4+T cells and thymocytes of mice
    Huai, Jisen
    Firat, Elke
    Niedermann, Gabriele
    GENESIS, 2007, 45 (07) : 427 - 431
  • [9] Rfx2 Stabilizes Foxj1 Binding at Chromatin Loops to Enable Multiciliated Cell Gene Expression
    Quigley, Ian K.
    Kintner, Chris
    PLOS GENETICS, 2017, 13 (01):
  • [10] Guidance of sentinel lymph node biopsy decisions in patients with T1-T2 melanoma using gene expression profiling
    Vetto, John T.
    Hsueh, Eddy C.
    Gastman, Brian R.
    Dillon, Larry D.
    Monzon, Federico A.
    Cook, Robert W.
    Keller, Jennifer
    Huang, Xin
    Fleming, Andrew
    Hewgley, Preston
    Gerami, Pedram
    Leachman, Sancy
    Waynes, Jeffrey D.
    Berger, Adam C.
    Fleming, Martin D.
    FUTURE ONCOLOGY, 2019, 15 (11) : 1207 - 1217